Cargando…
Chagas disease research and development: Is there light at the end of the tunnel?
Chagas disease, or American trypanosomiasis, is the result of infection by the parasite Trypanosoma cruzi. It is endemic in Latin America, and spreading around the globe due to human migration. Although it was first identified more than a century ago, only two old drugs are available for treatment a...
Autor principal: | Chatelain, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196238/ https://www.ncbi.nlm.nih.gov/pubmed/28066534 http://dx.doi.org/10.1016/j.csbj.2016.12.002 |
Ejemplares similares
-
Machine learning applications in drug development
por: Réda, Clémence, et al.
Publicado: (2019) -
The promises of quantitative systems pharmacology modelling for drug development
por: Knight-Schrijver, V.R., et al.
Publicado: (2016) -
Re-imagining the future of diagnosis of Neglected Tropical Diseases
por: Peeling, Rosanna W., et al.
Publicado: (2017) -
Worsening of Verbal Fluency After Deep Brain Stimulation in Parkinson's Disease: A Focused Review
por: Højlund, Andreas, et al.
Publicado: (2016) -
An Artificial Neural Network Integrated Pipeline for Biomarker Discovery Using Alzheimer's Disease as a Case Study
por: Zafeiris, Dimitrios, et al.
Publicado: (2018)